Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Consolidated Net Income of $170.0 million for Q2 2023, down 1.16% quarter-over-quarter from $172.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Consolidated Net Income history runs 15 years deep, the most recent figure standing at $170.0 million for Q2 2023.
- In Q2 2023, Consolidated Net Income changed N/A year-over-year to $170.0 million; the TTM figure through Mar 2026 stood at $170.0 million (down 50.29% YoY), while the FY2026 annual figure was $452.0 million, down 32.64% from the prior year.
- Consolidated Net Income for Q2 2023 stood at $170.0 million, down from $172.0 million in the prior quarter.
- The five-year high for Consolidated Net Income was $172.0 million in Q1 2023, with the low at -$108.0 million in Q3 2020.
- The 5-year median for Consolidated Net Income is $105.5 million (2019), against an average of $88.6 million.
- The sharpest annual moves came in 2019 and 2020: Consolidated Net Income surged 126.98% in 2019, then sank 258.82% in 2020.
- Dr Reddys Laboratories' Consolidated Net Income stood at $68.0 million in 2019, then tumbled by 258.82% to -$108.0 million in 2020, then surged by 224.07% to $134.0 million in 2021, then slipped by 12.69% to $117.0 million in 2022, then surged by 45.3% to $170.0 million in 2023.
- Business Quant data shows RDY's Consolidated Net Income at $170.0 million in Q2 2023, $172.0 million in Q1 2023, and $117.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 170.00 Mn |
| Mar 31, 2023 | 172.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 |
| Jun 30, 2021 | 134.00 Mn |
| Mar 31, 2021 | 77.00 Mn |
| Sep 30, 2020 | -108.00 Mn |
| Jun 30, 2020 | 104.00 Mn |
| Mar 31, 2020 | 79.00 Mn |
| Sep 30, 2019 | 68.00 Mn |
| Jun 30, 2019 | 107.00 Mn |
| Mar 31, 2019 | 143.00 Mn |
| Dec 31, 2018 | 63.00 Mn |
| Sep 30, 2018 | 70.00 Mn |
| Jun 30, 2018 | 66.00 Mn |
| Mar 31, 2018 | 63.00 Mn |
| Dec 31, 2017 | 44.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Dec 31, 2016 | 22.00 Mn |
| Sep 30, 2016 | 86.00 Mn |